Correlation Between Elevation Oncology and Pyxis Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Pyxis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Pyxis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Pyxis Oncology, you can compare the effects of market volatilities on Elevation Oncology and Pyxis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Pyxis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Pyxis Oncology.

Diversification Opportunities for Elevation Oncology and Pyxis Oncology

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Elevation and Pyxis is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Pyxis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyxis Oncology and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Pyxis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyxis Oncology has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Pyxis Oncology go up and down completely randomly.

Pair Corralation between Elevation Oncology and Pyxis Oncology

Given the investment horizon of 90 days Elevation Oncology is expected to generate 0.7 times more return on investment than Pyxis Oncology. However, Elevation Oncology is 1.43 times less risky than Pyxis Oncology. It trades about 0.05 of its potential returns per unit of risk. Pyxis Oncology is currently generating about -0.15 per unit of risk. If you would invest  61.00  in Elevation Oncology on September 13, 2024 and sell it today you would earn a total of  6.00  from holding Elevation Oncology or generate 9.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Elevation Oncology  vs.  Pyxis Oncology

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Elevation Oncology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical and fundamental indicators, Elevation Oncology showed solid returns over the last few months and may actually be approaching a breakup point.
Pyxis Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pyxis Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Elevation Oncology and Pyxis Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Pyxis Oncology

The main advantage of trading using opposite Elevation Oncology and Pyxis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Pyxis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyxis Oncology will offset losses from the drop in Pyxis Oncology's long position.
The idea behind Elevation Oncology and Pyxis Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Directory
Find actively traded commodities issued by global exchanges